The article discusses the majority public and medical support for legal cannabis against opposition in Washington, DC. It highlights the potential impact of a government shutdown on the rescheduling process of marijuana under federal law, which has been a priority for the Biden administration. Rescheduling marijuana to Schedule III could enhance research, patient care, and small businesses' tax benefits. However, efforts to reschedule are at risk from a Republican-led Appropriations Committee and could face further delays due to a shutdown impacting the review process by the White House Office of Management and Budget.
The potential government shutdown could significantly impact the ongoing process of marijuana rescheduling, which has been a major focus of the Biden administration since 2022.
Rescheduling would not only provide a path for increased research and patient care from medical marijuana, but would allow mom and pop businesses to have the same tax benefits.
The Drug Enforcement Administration is currently considering rescheduling marijuana from Schedule I to Schedule III, which could have far-reaching implications for the cannabis industry.
Despite state legalizations, the cannabis industry faces obstacles due to federal regulations and potential setbacks from current legislative discussions.
Collection
[
|
...
]